BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 28131138)

  • 41. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
    Lin X; Fan Y; Zhang Z; Yue H
    Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
    Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe hypercalcaemia of primary hyperparathyroidism: Could giant adenoma be the real culprit rather than carcinoma?
    Gücek Haciyanli S; Acar N; Gür EÖ; Çelik SC; Karaıslı S; Dilek ON; Haciyanli M
    Ann R Coll Surg Engl; 2020 May; 102(5):363-368. PubMed ID: 32233846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management.
    Pyram R; Mahajan G; Gliwa A
    Maturitas; 2011 Nov; 70(3):246-55. PubMed ID: 21943558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation.
    Howson P; Kruijff S; Aniss A; Pennington T; Gill AJ; Dodds T; Delbridge LW; Sidhu SB; Sywak MS
    Endocr Pathol; 2015 Sep; 26(3):250-4. PubMed ID: 26091632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
    Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
    J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperparathyroidism: primary or secondary disease?
    Cordellat IM
    Reumatol Clin; 2012; 8(5):287-91. PubMed ID: 22089066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contemporary Multimodality Imaging of Primary Hyperparathyroidism.
    Naik M; Khan SR; Owusu D; Alsafi A; Palazzo F; Jackson JE; Harvey CJ; Barwick TD
    Radiographics; 2022; 42(3):841-860. PubMed ID: 35427174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.
    Glasgow C; Lau EYC; Aloj L; Harper I; Cheow H; Das T; Berman L; Powlson AS; Bashari WA; Challis BG; Marker A; Moyle P; Mohamed IA; Schoenmakers N; Broomfield J; Oddy S; Moran C; Gurnell M; Jani P; Masterson L; Fish B; Casey RT
    J Clin Endocrinol Metab; 2022 May; 107(6):1706-1713. PubMed ID: 35150267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple organ dysfunction caused by parathyroid adenoma-induced primary hyperparathyroidism.
    Fu QY; Ma L; Yang ZB; Pao T
    Niger J Clin Pract; 2014; 17(1):122-4. PubMed ID: 24326822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Primary hyperparathyroidism as a cause of hypercalcemia in a patient with breast cancer].
    Zajícková K
    Cas Lek Cesk; 2010; 149(11):546-8. PubMed ID: 21391355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: focus on calciomimetics].
    Brardi S; Ponchietti R; Duranti E
    G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
    Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
    Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.
    de la Plaza Llamas R; Ramia Ángel JM; Arteaga Peralta V; García Amador C; López Marcano AJ; Medina Velasco AA; González Sierra B; Manuel Vázquez A; Latorre Fragua RA
    Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):659-669. PubMed ID: 29209851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
    Peacock M; Bilezikian JP; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E9-18. PubMed ID: 20943783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of severe hyperparathyroidism in clinical practice. Case report].
    Biryukova EV; Shinkin MV; Podachina SV; Feidorov IY; Mikheeva OM; Zvenigorodskaya LA; Malkina NA; Synkova DA
    Ter Arkh; 2023 Dec; 95(12):1185-1191. PubMed ID: 38785059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxyphil parathyroid adenoma: a malignant presentation of a benign disease.
    Fleischer J; Becker C; Hamele-Bena D; Breen TL; Silverberg SJ
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5948-51. PubMed ID: 15579742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normocalcemic primary hyperparathyroidism-characteristics and clinical significance of an emerging entity.
    Shlapack MA; Rizvi AA; Lopez FA
    Am J Med Sci; 2012 Feb; 343(2):163-166. PubMed ID: 22173046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Usefulness of intraoperative parathormone measurement to predict surgical cure in primary hyperparathyroidism].
    Domínguez JM; Velasco S; Goñi I; León A; González H; Claure R; Arteaga E; Campusano C; Fardella C; López JM; Mosso L; Rodríguez JA; González G
    Rev Med Chil; 2009 Dec; 137(12):1591-6. PubMed ID: 20361135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.